I have been on Entecavir 0.5mg for over 6 years and my HBV DNA is nearly undetectable. I will see my doctor tomorrow and what tests should I perform so as to assess whether I will benefit from the Entecavir + Interferon combo treatment (i.e. higher chance to achieve Hbsag seroconversion.) Many thanks.
Yes, I also thought etv is not effective for me but my doctor (as my previous post mentioned) advised me to use entecavir 1mg instead of adding on tdf. I will see him again tomorrow and don't know what to do.
no increasing etv dose is useless, 1mg has even less potency than 0.5mg on latest reports and doesn t work to prevent resistance, it really makes no sense
best option is 6months of combo etv+tdf, if hbvdna becomes totally und etv can be discontinued
unless your doctor has benefits from the drug maker to prescribe etv what he says makes no sense, tdf is more potent, no resistance, cheaper and same effect on kidneys function as etv
or you may try intf+etv 1mg, intf should work on the partial response of etv and little hbvdna detactable might stimulate intf response more
yes make tests to check for resistance mutations, genotype, hbsag quantity, whatever the results i d try intf anyway unless we find a very high hbsag up to 10.000-20.000iu/ml
Just want to mention some latest research findings:
1. The rate of HBeAg seroconversion using antivirals is lower in real practice than those reported in clinical trial
2. Intensifying entecavir (Baraclude) treatment for hepatitis B by adding pegylated interferon lowers HBV viral load and increases the likelihood of hepatitis B "e" antigen (HBeAg) loss, according to a report at the American Association for the Study of Liver Diseases Liver Meeting (AASLD 2012) last month in Boston. A related study found that hepatitis B surface antigen (HBsAg) levels during treatment can be used to predict response to interferon.
Nucleoside/nucleotideanalog antivirals that interfere with the hepatitis B virus (HBV) lifecycle are standard treatment for chronic hepatitis B. They perform well for lowering HBV DNA levels, but serological response, including HBeAg and HBsAg loss or seroconversion, occurs in only a minority of patients.
Interferon -- long the mainstay of hepatitis C treatment -- stimulates the natural immune response against viral infections and may contribute to improved outcomes for hepatitis B as well.
Milan Sonneveld from Erasmus University Medical Center in Rotterdam and the ARES study team conducted a controlled trial that enrolled 184 HBeAg positive patients with compensated liver disease at 15 sites in Europe and China. About 60% were of Asian ethnicity and all major HBV genotypes were represented.
One group was randomly assigned to take 0.5 mg/day entecavir monotherapy for 48 weeks; the other group received the same dose of entecavir, but after 24 weeks of monotherapy they added 180 mcg/week pegylated interferon alfa-2a (Pegasys) and continued on triple therapy through week 48.
74% of participants in the entecavir monotherapy group and 83% in the interferon add-on group achieved HBV DNA < 200 IU/mL, but the difference did not reach statistical significance
53% and 61%, respectively, reached HBV viral load < 20 IU/mL, again not a significant difference.
8% of patients the entecavir-only group and 18% in the add-on group experienced HBeAg loss, which just missed being significant (P=0.068).
In a multivariate analysis, the only factors independently associated with combined response were:
o HBsAg level at baseline: odds ratio 0.42, indicating that a lower level raised the likelihood of response;
o Addition of pegylated interferon: odds ratio 3.78, or nearly quadruple the likelihood of response.
Adding pegylated interferon to entecavir was generally safe and well-tolerated.
5 people experienced serious adverse events, including 3 ALT flares during the entecavir monotherapy phase.
Neutropenia (0% vs 23%) and thrombocytopenia (0% vs 8%) were significantly more common in the add-on group compared with the monotherapy group; no one in either arm developed anemia.
2 people developed severe neutropenia while on pegylated interferon.
"Addition of pegylated interferon alfa-2a to entecavir monotherapy increases HBV DNA, HBeAg, and HBsAg decline," the reseachers concluded. "Addition of pegylated interferon alfa-2a to potent [nucleoside/nucleotide] analogue therapy may increase chances of finite therapy."
How about side effects after a liver transplant not afraid of those? You have e antigen positive hbv. Why they were treating you with nucs then interferon was the rightvway tovgo about it. These doctors who prescribe anti aids drugs to us kill us really. Speak with honest docs they will tell you
With this study result, should I still try interferon?
Entecavir and interferon-α sequential therapy in Japanese patients with hepatitis B e antigen-positive chronic hepatitis B.
Enomoto M, Nishiguchi S, Tamori A, Kobayashi S, Sakaguchi H, Shiomi S, Kim SR, Enomoto H, Saito M, Imanishi H, Kawada N.
Department of Hepatology, Osaka City University Graduate School of Medicine, 1-4-3 Asahimachi, Abeno-ku, Osaka, 545-8585, Japan.
The outcomes of sequential therapy with lamivudine followed by interferon have been unsatisfactory in Japanese patients with hepatitis B envelope antigen (HBeAg)-positive chronic hepatitis B. However, the efficacy of sequential therapy with entecavir and interferon remains unclear.
Twenty-four HBeAg-positive patients (23 men and 1 woman; mean age 39 ± 7 years) received entecavir 0.5 mg alone for 36-52 weeks, followed by entecavir plus interferon-α for 4 weeks, and lastly by interferon-α alone for 20 weeks. Twenty-three patients had genotype C infection, and one had genotype A infection.
No entecavir-resistant mutant variants emerged in any patient. Hepatitis flare occurred in three patients during interferon-α treatment after the withdrawal of entecavir, but none had hepatic decompensation. Serum hepatitis B surface antigen levels did not change during or after therapy. Serum hepatitis B core-related antigen levels were significantly decreased at the start (P < 0.0001) and at the end of interferon-α treatment (P < 0.0001), but returned to baseline levels after treatment. Twenty-four weeks after the completion of the sequential therapy, a sustained biochemical, virological, and serological response was achieved in 5 (21 %) patients. The proportion of patients in whom HBeAg was lost during entecavir treatment was significantly higher among those with a sustained response than among those with no response (P = 0.015).
The rate of response to sequential therapy with entecavir and interferon-α in Japanese patients with HBeAg-positive chronic hepatitis B was not higher than the rate in previous studies of lamivudine followed by interferon.
No advice, just some opinions. As you can see from both studies, responses to ENT + PEGINFN combo vary. Of course, your situation is not typical of both studies. Firstly, I want to ensure that you have complied with your daily intake of ENT on an empty stomach. HK has some of the most experienced liver doctors in the world, so you have an advantage there. Finally, I would check your quantitative HBsAg level before deciding.
I had been taking entecavir at 1700 hrs everyday (I would finish taking my lunch at 1400 hrs and would start my dinner after 1900 hrs). A few months ago, I changed to take entecavir at 2300 hrs (just before sleep) and I would normally finish my dinner before 2030 hrs. Is this routine ok for the empty stomach requirement?
Yes, I agree that Hong Kong has some of the most experienced liver doctors (as we have my Hep B carriers here). But my doctor would like to prescribe entecavir 1mg and I don't want to take entecavir indefinitely (due to its carcinogenicity). That's why I ask if my chance for ent + interferon combo. I will definitely ask him to test my HBsAg quantity today.
Thanks for the info. Yes, most people ENT just before going to bed. As for carcinogenicity, I believe there is on-going monitoring of this since ENT was approved by FDA because ENT tested positive in for carcinogenicity in an animal study. So far, FDA has not issued any warning nor made changes to the label information.
Still 180 copies/ml, i.e. 33 iu/ml, is a very very low number, below the "detectable limit" of many assays. Some research indicated INTFN can reduce level of HBeAg (as well as HBsAg), so it should help with your seroconversion, whether it is desirable to have the e-Antigen seroconversion is not clear to me.
Just my opinions.
He advised me to continue 0.5mg entecavir monotherapy as I am still HBeAg+ as he predicted that my outcome using ent + intf combo will be the same as the ent mono. I did request to test for HBsAg quantity and will discuss with my doctor again when I know my baseline HBsAg to see if it is worthwhile to add intf.
Thank you all for sparing your time in giving me valuable opinions.
I am sure it will not rebound soon, but in the future, I would say no too. Of course, it is just my opinion. So far, research indicates response to Entecavir continues to be durable, that is, if you keep on taking Entecavir, you keep getting response. It seems your liver is in good condition (4.2Kp), hbvdna undetectable and I bet your ALT is also normal. So what can you expect in the future? I think, after you seroconvert your e-antigen, after a further 12 month consolidation, you may consider stopping all treatment and see whether your immune system can maintain control on its own. This seems to the view favored by researchers in Taiwan. Or you may consider combination with Peg INFN with the view to aim at clearing your HBsAg. Or you may just continue Entecavir until you seroconvert your s-antigen too.
So I think you are in a very good position, your HBsAg level may give you a better prediction of what is going to happen next.
HBsAg of 456 iu/ml is a very good number. If you were HBeAg negative, you would be considered "inactive". It is certainly favorable to clearance by PegIFN treatment. I cannot give you an estimate. You may like to consult your doctor or seek an opinion from one of the experts.
In a recent study in China, 16 HBeAg negative inactive carriers with HBsAg < 200 iu/ml received PegIFN treatment and all of them cleared their HBsAg. Your situation is different as you are on antiviral treatment and still HBeAg positive. However there are studies that indicate PegIFN is more effective for HBeAg positive patients than HBeAg negative.
your alt are not normal, those ranges are so obsolete alt range has been updated few years ago to alt less than 30 for men and less than 19 for women
to know if you are inactive you need fibroscan less than 6kpa, hbsag quantity in iu/ml less than 1000iu/ml genotype A and D, less than 100iu/ml C and B (not sure about b and c so i ve used a very low level) and hbvdna quantity in iu/ml less than 2000iu/ml
even your alt are not normal so you are not an inactive carrier at all, your doctors may be very very ingnorant on hbv and not updated on the diseases since years better change doctors
afp is useless as marker of HCC, it stays normal in most of HCC cases and gets high with alt flares inflammation....just a mess, US every 6 months is the best way for monitoring HCC prevention
My doctor told me as ALTs are within range no need to do the HBV DNA and no need to take medicine is it write.
change doctor this is from prehistory and not updated on personalized hbv cure at all, if he is not able to manage an easy patient like you who can clear hbv he is just selling drugs to the chronic carriers...i d call him seller and not doctor.since i met such doctors myself too and they made me a lot of damage today i dont even consider them doctors and just want the best doctors/researchers
etv may clear your hbv in a very long time or hbv may mutate hbsag/hbcag and escape your immune response now, you better use peginterferon add on and stop it now, when you look for another doctor just ask for "expert liver specialist updated with latest personalized hbv therapy which is made by combo antivirals plus peginterferon"
as said in previous post your alt is not normal both the lab you use and your doctor are 2-3years not updated about hbv, this is not tollerable becuase everything can change from year to year in the "cure of hbv" not just managment
Your ALT is mildly elevated by the new standards. To be certain you do not require treatment at this stage, you should measure your viral load(hbvdna). Hep B is a chronic disease and can be tricky. You should not rely on just one test, or test results at a single time point.
You are und now on entecavir, but it was pos for 6 years, it might be smart to switch to tenofovir.
If you start ent plus interferon now, you do have a small chance to clear the surface antigen. Better, much better than patients with a higher hbsag, but still small, maybe 30% if limited to one year, getting a little higher with extended treatment. But the side effects are not trivial, so it is a somewhat difficult decision.
Ezetimibe is a fascinating add on, but we need to see first how stefanos surface antigen will further develop with this treatment. There is a first hint of an effect, but we need to see more.
Your response to entecavir was suboptimal since it took you 6 years to reach an uncertain undetectable status. Entecavir resistance can start with mild partial resistance mutations.
While it might not ever progress any further, tenofovir is very available and even much less prone to any resistance.
Furthermore tenofovir is an obligate chain terminator and will never be incorporated in mitochondrial or any DNA, since it is lacking the connecting hydroxyl group. Entecavir however can rarely be incorporated into the growing DNA chain, this feature might be the reason for the high cancer incidence in the animal studies as Stephen mentioned. Thus far it does not seem to be a major concern in humans, the FDA has requested a long term study on this from BMS, no red flags seem to have surfaced yet.
In case I need to switch to tenofovir, should I first keep taking entecavir concurrently for six months before stopping it as previously advised by Stefano.
Provided I can tolerate the side effects (I am now 39 y.o. with 4.2KPa fibroscan result last December and recent ALT of 25), do you think it is worthwhile for me to start interferon treatment with my HBsAg = 456 IU/ml?
So in what range of the HBsAg level will have a higher chance of clearing HBV?
You say find a doctor that has an up to date knowledge on treating hbv. I have seen maybe 50 people already over 7 year period and they have no clue what they are doing. Just following treatment guide line they were given. And that is it.
It is really a frustrating feeling. But nothing but nucs is available here. :( and when you try to reason with these so called doctors they get upset and leave. That is what we have to deal with.
I am open to go to any country they take me for real treatment. And I am sure people are. But it really ***** how they treat us here for the amount of money we pay. We pay more then you Europeans. Docs hers minimum make 150k that is just primary care internal medicine docs. It is unbelievable how bad things are regarding hbv care and attitude of these so called doctors. Bunch if greedy snobs that only care about money.
I will soon discuss with my doctor whether I should start the combo i.e. adding interferon on top of my existing entecavir treatment. He seems unconvinced that interferon will work on my case and so if you have any research papers to share, I could show him for further discussion. Many thanks.
There are almost no publications on this combo at this time.
The results are only good when the starting hbsag quant is very low and the dna is und.
Here is an example of a nuc first then ifn add on therapy trial.
J Clin Virol. 2012 May;54(1):93-5. doi: 10.1016/j.jcv.2012.01.024. Epub 2012 Feb 24.
Adding pegylated interferon to a current nucleos(t)ide therapy leads to HBsAg seroconversion in a subgroup of patients with chronic hepatitis B.
Kittner JM, Sprinzl MF, Grambihler A, Weinmann A, Schattenberg JM, Galle PR, Schuchmann M.
I. Medical Department, University Hospital Mainz, Langenbeckstr. 1, 55131 Mainz, Germany. Jens.firstname.lastname@example.org
Nucleos(t)ides effectively halt disease progression in hepatitis B but require long-term medication.
To determine whether add-on of peg-IFN to an ongoing nucleos(t)ide therapy accelerates decline of HBsAg and induces seroconversion.
We observed HBsAg kinetics in 12 patients on a stable oral therapy with undetectable HBV-DNA who additionally received peg-IFN-alfa 2a as an individualized therapy. 3 patients were HBeAg positive. Mean baseline HBsAg was 4695 (range 16-15,120)IU/ml.
A continuous decline of HBsAg was observed in 2 patients. The slope, respectively, became detectable at week 8 or 16. HBsAg had dropped by 2.90log(10) or 4.25log(10) fold at week 48, and anti-HBs appeared at week 40 or 32. Patient A - HBe-positive, genotype A, F3 fibrosis - had been HBV-DNA negative for 10 months receiving entecavir plus tenofovir. Previous therapy with peg-IFN had been unsuccessful, but now the patient experienced HBeAg seroconversion at week 24. Patient B - HBeAg negative, genotype D, cirrhosis - had a low initial HBsAg level of 16U/l. Receiving entecavir, his HBV-DNA had previously been non-detectable for 27 months. In the remaining 10 patients HBsAg declined only by a mean of 0.09log(10) (range 0.01-0.25log(10)) after 8-24 (mean 16.4) weeks, and therefore, peg-IFN was stopped. No unexpected side effects were observed.
We observed that the add-on of peg-IFN induced HBsAg seroconversion in 2 out of 12 patients. Response rates may have been higher with prolongation of therapy. The add-on concept merits to be evaluated in a clinical trial
Just wanted to tell you that you should not be that scared of IFN sides.
In my case its just being tired on afternoons just after shot and dehydration so I drink a lot of water. Besides that maybe I could say trouble with concentration but I'm not sure if its the IFN or the nerves with the disease.
I would try Interferon for sure. Week 12 or 24 you can check HBsAg again and check if you are responding so its not that long.
Thanks a lot but the thing is whether my doctor is willing to start the interferon. The other concern of mine is that I may not be able to go on a trip if the injection of interferon has to be done by medical practitioners.
Not sure at this moment yet. I am on week 18 with injections.
My DNA keeps the dropping curve from 170000 IU/ml baseline to 3000 IU/ml on week 12, but my HBsAg is acting up baseline 4400 dropped to 3700 w4 and goes back up 4400 w8 and to 4700 w12.
Doc says we need to wait for W24 to see what is the pattern of it and then rethink my treatment.
You asked for literature for your doctor. Here is the abstract that showed the best success rate. Note that all cleared patients had very low hbsag quant at start.
Improvement of HBsAg Loss by additional PEG IFN in Nucleosides Analogs treated Chronic Hepatitis B Patients
Zhongwen Wu, Jifang Sheng, Lanjuan Li; State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, Department of Infectious Diseases,the First Affiliated Hospital, College of Medi- cine, Zhejiang University, Hangzhou, China
Background and Aim: Suppression of HBV-viral load by nucleos(t)ide analogs(NAs) treatment reduces disease progres- sion but requires indefinite treatment. Hepatitis B surface anti- gen (HBsAg) loss or seroconversion is a rare event after long term treatment of NAs. PEG-IFN could induce sustained immune response and lead a significant decline of serum HBsAg., Our study aimed to explore whether NAs treated patients who have achieved sustained virological response (SVR, defined as HBV- DNA < 1000 copies/ml) and obvious decrease of HBsAg level, add on the treatment of peg interferon alpha-2a for 48 weeks could achieve high HBsAg declination and even got HBsAg loss. Methods: 32 chronic hepatitis B patients have received NAs for 1.5-4 years, 65% of the patients achieved HBeAg sero- conversion. all patients with HBV-DNA < 103 copies/ml, obvi- ous decrease of HBsAg level 100-500 IU/ml (using time-resolved immunofluorometric assay) were enrolled into the study and divided into two groups: GroupA with 16 patints (M/F: 14/2, median age 31years, 5 HBeAg positive,)
received additional peg-interferon alpha 2a (180ug/w) for 48 weeks; other 16 patients (M/F: 13/3, median age 34 years, 6 HBeAg positive) in Group B continued the NAs therapy for 48 weeks. Median baseline HBsAg was 209.64 IU/ml in Group A and 193.18 IU/ml in Group B. Results: In GroupA, eight out of 16 patients (50%) had a continuous HBsAg decline which lead to HBsAg loss (<0.5 IU/ml), HBsAg seroconversion was observed in five of them (31.3%) . Quantitative HBsAg highly decreased to below 10IU/ml in twelve patients (75%). Two out of 5 HBeAg positive patients had HBeAg seroconversion, 1 had HBeAg loss, In Group B, no significant HBsAg decline was observed at week 48, even fluctuated round to the baseline level, and none of six HBeAg patients in group B achieved HBeAg loss or seroconversion. Conclusions In chronic hepatitis B patients, with SVR and obvious decrease of HBsAg level after NAs treatment add on a finite course of peg interferon alpha- 2a treatment could significantly drop the HBsAg level (75%), even lead to HBsAg loss /seroconversion (50%) . This appears to be a promising approach for further investigation.
Any change in qHbs after 2 courses? I am on my 28th week of Pegasys. Hbs goes up and down within 10% range. Baseline is 10 000 iu/ml. After 24th week no change in quantity of hbs my doctor suggests me 96 weeks of interferon instead of 48 weeks. So far no decline in qHbs. Some papers say if no decline on 24 weeks then useless to continue interferon but my doctor is of diffirent opinion.
Hi. I have similar experience - my hbsag is just fluctuating and I'm at week 18.
How is your DNA level and ALT during treatment?
I saw some chart where there is a small chance of SVR even if HBsAg doesn't decline so lets not give up.
because Hep b is not only about HBV DNA but qHbs to me. Being undetectable in viral low is so much depressing for me knowing I have many Hbs and the only possible medicine affecting hbs is interferon that's why i started tx. Perhaps getting undetectable with interferon gives more advantages then getting same with NUCs, I do not know, I hope so.
I will meet my doctor tomorrow to discuss with him whether I should add-on IFN to my ETV monotherapy. While I the add-on treatment might give me a chance of getting rid of Hep B, but I am also concerned about whether the treatment may poise negative effects on my general health and also turning my chronic hepatitis into acute one. Any comments are greatly appreciated. Many thanks.
being under etv will make any possible alt flare a totally non issue, remember that even compensated cirrhotics can be treated by peg.i d definitely go in to etv+pegintf+simvastatin your levels of hbsag are the same as otan and she/he cleared by 16weeks on pegintf+sim
so you are in such a favourable status that hbsag may even be cleared before the first round of tests which is ususally at 12-24 weeks
I just had my first shot of IFN this morning and I developed fever (39 C by ear thermometer). The fever subsided to 38 C after taking 1 pill of 500mg paracetamol. Other than fever (and some flu-like symptoms) and high pulse rates (about 80 - 90 pulses per minute), I feel generally fine.
Just wanna ask how long will the fever last and will you continue your daily routines e.g. physical exercise?
Furthermore, mine IFN is packaged in pre-filled syringe and the nurse recommends me to place the syringe in room temperature for about 1 hour before injection. Will this affect the effect of the IFN?
I think I had 38 degrees but in my case its very hard to tell as when I had my first injection as I had a mild cold and I'm not sure if I should assign my 38 fever and cold sympthoms to the regular cold or to IFN. Nevertheless they went away within 3 days.
I didn't check my temperature that often as I felt pretty good in general. I think you need not to worry about temperature and stuff like that if you feel ok.
You know your organism best and just adjust to it - if you feel tired then rest/sleep. In my case even 20 minutes of rest/sleep works wonders on the afternoons.
Nobody told me about warming up the synergies before injection so I just take it out of the fridge and inject. I think if it was important they would label it properly but as stef said warming up this amount of liquid is a matter of minutes.
I know first injection is a little panic on whats gonna happen but try and drink a lot of water and heads up its gonna be less and less sides every injection.
Thanks for your prompt reply. Even a 30-minute moderate jogging is not recommended? In fact, I quite like cycling and will usually ride for 1 hour in the early morning before going to work. Is this forbidden?
I know high blood pressure starts 140+ and I somehow approach this ceiling and don't know whether it is due to entecavir or other factors (I have a very bad mood after being diagnosed with bronchiectasis half years ago) since I have very normal blood pressure last September. :(
It is so great to see that your treatment is working for u. I'm currently in almost the same state as u were before u started IFN. But anyway, hope u get rid of hep b as soon as possible. Can't wait to hear good news from u!
This morning, my wife helped me to do the interferon injection. When the needle was in my belly, she pull the syringe to see if there is blood coming out. She did and saw no blood. Then she performed the injection but when she pull out the needle, we found that trace of blood was inside the syringe. Just want to know if the interferon was injected into a blood vessel, any adverse effect or will it render this injection useless?
I just got my latest qHbsAg result which indicates my level is <0.05 IU/ml as at 19 February 2014, meaning negative. My last qualitative test on HBsAg and HBeAg was still positive as at 6 February 2014.
My questions are whether the threshold in determining positive / negative is different for the quantitative and qualitative tests?
What should I do now? e.g. check for whether I have Anti-HBs or to inject Hep B vaccine in order to achieve s-seroconversion? If I do not develop Anti-Hbs, should I continue peg-interferon injections beyond 48 weeks?
also consider to keep entecavir for 6-12 months even when hbsab becomes detactable, there are no guidelines for this but researchers that cure patients this way keep antiviral for 6-12 months after peg is finished just to be sure no relapse
you absolutely need to keep peg beyond 48weeks until we have good hbsab, check this in advance and look for another doctor if there is any trouble
i remember otan got n touch with a researcher/doctor in HK or singapore, check her posts, he was very expensive but studying and treating to make hbsab once hbsag is neg
he is using peg, zadaxin and hbv vaccine
or simply look for another doctor willing to go over 48weeks
the maximum peginterferon strength is after 48weeks, in the second year of use, and this is quite normal to use 96weeks on responders
you may also start the hbv vaccine or zadaxin before 48weeks if these are non prescription in your country
Thanks. Since I have hep B since birth and I am now 40 years old, is my chance of getting liver caner and fibrosis the same as before? Should I continue to have ultrasound screening of my liver every 6 months as before?
is my chance of getting liver caner and fibrosis the same as before?
no in any case, also data we have is too little to say hcc risk is increased, we may say this on cirrhotic patients.i suggest you have regular nagalase screening if nagalase is normal there is no way to develop cancer, it also takes very long time for cancer to develop after nagalase become abnormal
Should I continue to have ultrasound screening of my liver every 6 months as before?
yes and if you add nagalase monitoring too you can be sure to have no surprise
I am also chronoc hepb patient
my latest blood report are here
plzz give me advice how to cure hbv
Hbsag confirmation test positive.
Antihbc total Reactive (CMIA) 12.86
antihbc IgM non reactive.(CMIA) 0.5
Antihbs Non Reactive.(CMIA) 0.81miu/ml
Hbeag Non Reactive(CMIA) 0.36
Hbv Dna Undetechable(PCR) <3.6 iu/ml
that s guidelines once hbsag neg and hbsab pos the antiviral must be kept to normalize and consolidate immune response (remember cccdna is still there)
i believe only italian guidelines took care of this, very few countries around the world are actually curing hbv patients and taking care of consolidation...maybe only few words about this by researchers/most expert liver specialists
I think there is always chance for hbsag relapse even when you test neg after inf course and in order to decide weather you need to go for next peg shot or maybe even go prolonged course you need to monitor your hbsag kinetics while on treatment. Just imagine if you were still hbsag positive on week 44 and started bebing neg on week 48. Is it wise to stop inf right away? or maybe prolong inf for a couple of month or so?
Sad news indeed. I rechecked my HBsAg on 10 September 2014 and got my result today that my HBsAg is 'POSITIVE' again i.e. my Hep B relapsed!
I have discontinued my interferon as scheduled (after 48 weeks) after I developed Anti-HBs in March 2014. I have not ceased and still continued to take entecavir 0.5mg daily as a precaution advised by you.
I did not get the vaccines (which I am terribly regretted). Kindly let me have your expert opinions. Many thanks.
another thing i dont have time to read the full post now but if you had only 48weeks of pegintf i strongly suggest to restart it.the most potent effect of peg on immune system is between first and second year (not shorter or longer), so this might be the best choice togheter with vit d or simvastatin as some of us are trying
Thanks for drawing my attention to Paris2013 case. The only difference between me and Paris2013 is that I achieved HBsAg undectable (I don't know whether it is equivalent to clearance) and then attained the Anti-HBs at 22mIU level (I know it is low but my doctor would not prescribe further interferon and I was too stupid to think I had already won the battle of HBV). Now I was tested positive for both HBsAg and HBeAg.
I haven't checked the HBsAg quantity but will do so these few days. What do you think about Paris2013's doctor about it is useless to repeat interferon as it appears that we (me and Paris2013) have no permanent control on the HBV.
Would studyforhope please kindly advise. Many thanks.
My opinion is that your hbsag titer went below cut off level (<0.05) while paris2013 was 0.09 iu/ml almost below. Both yours and her immune system should establish permanent control of hbv but for some reasons that did not happen. Meanwhile you both continued taking entecavir after pegasys but it did not help to keep hbsag cleared.
See page 18 of below presentation: http://www.aphc.info/pdf/2014/Luncheons_13012014/S-251/Jorg_PETERSEN.pdf
Some people clear hbsag with Baraclude mono without any relapse in the future, this is really possible while we have two members here that cleared hbs and relapsed. I already start thinking that hbsag relapse is irreversible.
let us wait intil your quant hbsag comes back. if your dr does not want to give you more interferon then there is very little that you can do to change the course. taking antivirals will slow the regrowth of the infected cell number.
i think if you retreat later with ifn you will have a response again. It is the lack of the proper epitope tcell clone combination and an insufficient cytokine milieu to keep the tcell clone in an effective state that limits the permanent internal control.
Thanks a lot for your prompt advice. While repeating IFN for another course is off the guideline in Hong Kong, I am not sure if there are doctors who will prescribe me a course of zadaxin. Btw, how long is a course of zadaxin?
My doctor just commented the effect of repeating IFN is very limited in my case as "No one know if my immune response can be further enhanced by
repeated another course of interferon."
I think I will check my qHBsAg before considering my further treatment regime.
I know Cyrus that it is frustrating when you almost cleared but relapsed, however look at the positive side of it that you responded to treatment and you are more likely to clear than many of us who still have long journey
hei cyrus, sorry to hear that you relaplsed, but it is good you checked it and find out soon, i dont think it will be a problem for you to clear it, as you took so many years entecavir. i wanted to ask you if you remember, can you tell me your hbvdna or hbsag quant before you start taking entecavir ?
My pre-treatment hbvdna was undetectable and HbsAg was 456iu/ml.
My doctor is still skeptical about the effectiveness for another course of interferon in my case. If I can't convince him, I will need to revert to more expensive private doctors. Should I restart treatment and when? I last finished 48-week interferon in mid March 2014.
Yep, it's a tough break. IFN is no picnic really. Every week you have to man up and take the shot. You have experience in that now but are you willing to go through that again? I would imagine your HBsAg will be in the low level.
I would give it another shot. As it's been done by trials, IFN can be a 96 weeks treatment plan as well.
I also suggest many things to boost immune function such as Vit D3 daily (at least 3000iu daily), herbs like curcumin and garlic, regular green tea and lots of vege juice.
once we know how much it relapsed we can say if re-treatment is urgent or not
for example if you relapsed to 10iu/ml it is very probable you will gain back immune control slowly
also try high dose vit d first making vitd25oh 100ng/ml and pth 10-20pg/ml (if target pth is not reached increase vit d to more than 150ng/ml, during this supplementation avoid milk and dairies and increase water to 2.5l per day, keep an eye on urine calcium too although 99% it won t rise
as to curcumin i dont know if that is ok, it has antinflamatory effect so according to the balance of immune system it can boost or suppress immune response.green tea, 4caps of cpffee per day and juices ok for sure
From my non expert advice, you are very lucky, definetly going to clear hbsag, but you need vaccine i guess and some treatment! That is a very very low quantity Wait for the expert opinion of our experienced friends here , stef and study
It's unclear if this will stay low or slowly return to higher values even if Entecavir is continued. In my opinion,if you want to stabilize or seroconvert the hbsag zadaxin for about 6 month is the most promising option, better than peg ifn. You would see success also in clearly increasing anti hbs titers. It should be easy to find a doc in hong kong who will prescribe zadaxin to you.
You might have a very low titre just above the threshold. It is not of major functional importance at this point. But the Tcell stimulation with Thymosin alpha/Zadaxin will likely get your Ab titre substantially up. Even then that is just mostly a good marker of improved Bcell function, but what matters will be the increased Tcell stimulation that will tend to attack and decrease remnant infected cells, a process that you cannot easily see or measure, but it will result in a neg surface antigen. there is also a factor of luck involved here, epitopes and matching Tcell clones must be available for stimulation or might occur de novo.
is zadaxin the best drug once we reach very low hbsag and some detectable hbsab?
or this combo might have more chances pegintf+ydf or etv+zadaxin+vit d3+hbv vaccine with aldara on skin where we inject vaccine?
aldara on the skin where you inject the vaccine is a very promising approach, and very available. The injections should be done intradermally, maybe 6 to eight injections spaced about 1cm on skin that has been prepared with aldara 2 hours before and again immediately before the injection. the doses for intradermal vaccinations are less than for intramuscular. having zadaxin in the mix would enhance it further, a Canadian trial has proven that.
Strong data support the notion that at a very low hbsag Zadaxin can induce a more permanent seroconversion than peg ifn.
it is unclear if antivirals at this time are helpful or harmful for the final effect. I have seen a paper where the group with antivirals did much worse than the one without it at this stage. Maybe the slightly enhanced virion production at this low stage gives incentives to immune processes.
Vit D is beneficial at all these approaches. It is unclear if very high doses improve the situation further over just high doses.
Copyright 1994-2016 MedHelp International. All rights reserved.
MedHelp is a division of Aptus Health.
This site complies with the HONcode standard for trustworthy health information.
The Content on this Site is presented in a summary fashion, and is intended to be used for educational and entertainment purposes only. It is not intended to be and should not be interpreted as medical advice or a diagnosis of any health or fitness problem, condition or disease; or a recommendation for a specific test, doctor, care provider, procedure, treatment plan, product, or course of action. Med Help International, Inc. is not a medical or healthcare provider and your use of this Site does not create a doctor / patient relationship. We disclaim all responsibility for the professional qualifications and licensing of, and services provided by, any physician or other health providers posting on or otherwise referred to on this Site and/or any Third Party Site. Never disregard the medical advice of your physician or health professional, or delay in seeking such advice, because of something you read on this Site. We offer this Site AS IS and without any warranties. By using this Site you agree to the following Terms and Conditions. If you think you may have a medical emergency, call your physician or 911 immediately.